Digital health technologies in clinical studies: an interview with Katie Garner, Signant Health

Written by Katie Garner (Signant Health)
Health data Interviews Medical devices, pharmaceuticals and vaccines Patient engagement Real-world evidence Regulation

Digital health technologies (DHTs) have emerged as transformative tools in health care, offering opportunities to optimize data collection processes, reduce participant burdens, and generate insights in real-world settings. In this interview, we speak with Katie Garner, Senior Manager, Patient- and Site-Centred Research, Signant Health to learn more about the latest guidance on DHTs and what researchers need to consider when using DHTs in clinical studies. Read more insights on DHTs from Katie Garner in this interview 'eCOA, BYOD and digital health in clinical trials.' What are your thoughts on FDA's recent guidance on DHTs in clinical studies? DHTs (including wearables...

To view this content, please register now for access

It's completely free